Edesa Biotech Inc. (EDSA) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 SPY COURT
MARKHAM, ON L3R 5H6
State of Incorp. BC
Fiscal Year End September 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
MRQ
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2018
9/30/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 5,4007,0917,8397,21410,3046,565
Cash and cash equivalents 5,4007,0917,8397,2144,2264,571
Short-term investments     6,0781,994
Receivables   3,30387411
Inventory, net of allowances, customer advances and progress billings     22468
Inventory     22468
Prepaid expense     87124
Other undisclosed current assets1,0372,001949803  
Total current assets:6,4379,09212,0918,10410,6566,758
Noncurrent Assets
Operating lease, right-of-use asset911897160
Property, plant and equipment91315151,062880
Long-term investments and receivables     4667
Long-term investments     4667
Intangible assets, net (including goodwill)2,1802,2812,3822,484  
Intangible assets, net (excluding goodwill)2,1802,2812,3822,484  
Deposits noncurrent assets173   1515
Other undisclosed noncurrent assets  171    
Total noncurrent assets:2,4542,4842,4942,6581,124962
TOTAL ASSETS:8,89011,57614,58510,76211,7807,720
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,7472,1221,3801,460493321
Accrued liabilities1522    
Other undisclosed accounts payable and accrued liabilities1,7322,1001,3801,460493321
Debt    70  
Other undisclosed current liabilities751979   
Total current liabilities:1,8222,1411,4591,530493321
Noncurrent Liabilities
Long-term debt and lease obligation  442194  
Long-term debt, excluding current maturities  44    
Liabilities, other than long-term debt 20 4730  
Accounts payable and accrued liabilities   4730  
Operating lease, liability 20 2194
Total noncurrent liabilities: 204468124  
Total liabilities:1,8422,1841,5261,654493321
Equity
Equity, attributable to parent, including:7,0499,39113,0586,63111,2877,399
Common stock  34,88818,50156,65348,352
Additional paid in capital13,03911,1764,8711,550  
Accumulated other comprehensive loss(215)(214)(205)(287)  
Accumulated deficit(52,419)(44,045)(26,496)(13,133)(50,431)(45,392)
Other undisclosed equity, attributable to parent 46,64342,473  5,0654,439
Other undisclosed equity    2,477  
Total equity:7,0499,39113,0589,10811,2877,399
TOTAL LIABILITIES AND EQUITY:8,89011,57614,58510,76211,7807,720

Income Statement (P&L) ($ in thousands)

12/31/2023
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2018
9/30/2017
Revenues  78010,340329212228
Revenue, net228
Operating lease, lease income  78010,340 
Cost of revenue   (101)(18)(312)(284)
Deferred sales inducement cost, amortization expense   (101)   
Other cost of operating revenue     (312)(284)
Gross profit:  78010,239311(100)(56)
Operating expenses(9,223)(18,371)(23,681)(6,730)(5,290)(5,453)
Other undisclosed operating income (loss)  (780)(10,239)18312284
Operating loss:(9,223)(18,371)(23,681)(6,401)(5,078)(5,225)
Nonoperating income (expense)849(21)10,3393740195
Investment income, nonoperating    387533
Gain (loss), foreign currency transaction, before tax(22)(21) (0)(35)162
Loss from continuing operations before equity method investments, income taxes:(8,374)(18,392)(13,342)(6,363)(5,038)(5,030)
Other undisclosed income from continuing operations before income taxes  844    
Loss from continuing operations before income taxes:(8,374)(17,548)(13,342)(6,363)(5,038)(5,030)
Income tax expense(1)(1)(1)(1)(1)(1)
Loss from continuing operations:(8,374)(17,549)(13,343)(6,364)(5,039)(5,031)
Loss before gain (loss) on sale of properties:(17,549)(13,343)(6,364)(5,039)(5,031)
Other undisclosed net income16,74935,098    
Net income (loss):8,37417,549(13,343)(6,364)(5,039)(5,031)
Other undisclosed net income (loss) attributable to parent(16,749)(35,098)1   
Net loss available to common stockholders, diluted:(8,374)(17,549)(13,342)(6,364)(5,039)(5,031)

Comprehensive Income ($ in thousands)

12/31/2023
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2018
9/30/2017
Net income (loss):8,37417,549(13,343)(6,364)(5,039)(5,031)
Other comprehensive loss (17,557)(773)   
Comprehensive income (loss):8,374(8)(14,116)(6,364)(5,039)(5,031)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(16,750)(17,549)85555  
Comprehensive loss, net of tax, attributable to parent:(8,375)(17,557)(13,261)(6,309)(5,039)(5,031)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: